C1 INHIBITOR DEFICIENCY
Clinical trials for C1 INHIBITOR DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new C1 INHIBITOR DEFICIENCY trials appear
Sign up with your email to follow new studies for C1 INHIBITOR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rapid relief from rare, painful swelling attacks
Symptom relief CompletedThis completed Phase 3 trial tested whether an oral capsule called deucrictibant could safely and quickly relieve sudden swelling attacks in people with hereditary angioedema (HAE). The study involved 134 participants aged 12 to 75 who took either the study drug or a placebo pill…
Matched conditions: C1 INHIBITOR DEFICIENCY
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
New pill tested to stop painful swelling attacks
Symptom relief CompletedThis study tested an oral medication called deucrictibant for quickly relieving painful swelling attacks in people with hereditary angioedema (HAE). Seventy-four participants with HAE took either the study drug or a placebo pill at home when an attack started. Researchers measure…
Matched conditions: C1 INHIBITOR DEFICIENCY
Phase: PHASE2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Mar 02, 2026 15:22 UTC